First Trust Nasdaq Pharmaceuticals ETF
Limited financial coverage for FTXH.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.
- IPO
- 2016
- HQ
- Wheaton, IL, US
Price Chart
- Market Cap
- $37.19M
- Div Yield
- 1.08%
- 52W High
- $39.18
- 52W Low
- $25.77
- 50D MA
- $35.10
- 200D MA
- $33.11
- Beta
- 0.49
- Avg Volume
- 8.44K
Get TickerSpark's AI analysis on FTXH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our FTXH coverage
Recent articles, reports, and earnings notes.
No research on FTXH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FTXH report →Similar companies
Peers in the same neighborhood.